{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:40:05Z","timestamp":1794332405816,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human cerebral organoids (COs) are three-dimensional self-organizing cultures of cerebral brain tissue differentiated from induced pluripotent stem cells. We have recently shown that COs are susceptible to infection with different subtypes of Creutzfeldt\u2013Jakob disease (CJD) prions, which in humans cause different manifestations of the disease. The ability to study live human brain tissue infected with different CJD subtypes opens a wide array of possibilities from differentiating mechanisms of cell death and identifying neuronal selective vulnerabilities to testing therapeutics. However, the question remained as to whether the prions generated in the CO model truly represent those in the infecting inoculum. Mouse models expressing human prion protein are commonly used to characterize human prion disease as they reproduce many of the molecular and clinical phenotypes associated with CJD subtypes. We therefore inoculated these mice with COs that had been infected with two CJD subtypes (MV1 and MV2) to see if the original subtype characteristics (referred to as strains once transmitted into a model organism) of the infecting prions were maintained in the COs when compared with the original human brain inocula. We found that disease characteristics caused by the molecular subtype of the disease associated prion protein were similar in mice inoculated with either CO derived material or human brain material, demonstrating that the disease associated prions generated in COs shared strain characteristics with those in humans. As the first and only in vitro model of human neurodegenerative disease that can faithfully reproduce different subtypes of prion disease, these findings support the use of the CO model for investigating human prion diseases and their subtypes.<\/jats:p>","DOI":"10.1186\/s40478-023-01512-1","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T16:17:38Z","timestamp":1676909858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sporadic Creutzfeldt\u2013Jakob disease infected human cerebral organoids retain the original human brain subtype features following transmission to humanized transgenic mice"],"prefix":"10.1186","volume":"11","author":[{"given":"Bradley R.","family":"Groveman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Race","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simote T.","family":"Foliaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Hughson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Baune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zanusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-1149","authenticated-orcid":false,"given":"Cathryn L.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"1512_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/brain\/awg125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, Ironside JW, Collinge J (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain J Neurol 126:1333\u20131346. https:\/\/doi.org\/10.1093\/brain\/awg125","journal-title":"Brain J Neurol"},{"key":"1512_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/labinvest.3700676","volume":"87","author":"S Notari","year":"2007","unstructured":"Notari S, Capellari S, Langeveld J, Giese A, Strammiello R, Gambetti P, Kretzschmar HA, Parchi P (2007) A refined method for molecular typing reveals that co-occurrence of PrP(Sc) types in Creutzfeldt-Jakob disease is not the rule. Lab Invest J Tech Methods Pathol 87:1103\u20131112. https:\/\/doi.org\/10.1038\/labinvest.3700676","journal-title":"Lab Invest J Tech Methods Pathol"},{"key":"1512_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P, Gelpi E, Giaccone G, Hauw JJ, Hoftberger R et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529. https:\/\/doi.org\/10.1007\/s00401-012-1002-8","journal-title":"Acta Neuropathol"},{"key":"1512_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1242\/dmm.012146","volume":"7","author":"WS Jackson","year":"2014","unstructured":"Jackson WS (2014) Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein. Dis Model Mech 7:21\u201329. https:\/\/doi.org\/10.1242\/dmm.012146","journal-title":"Dis Model Mech"},{"key":"1512_CR5","doi-asserted-by":"publisher","unstructured":"Artikis E, Kraus A, Caughey B (2022) Structural biology of ex vivo mammalian prions. J Biol Chem 298: 102181 https:\/\/doi.org\/10.1016\/j.jbc.2022.102181","DOI":"10.1016\/j.jbc.2022.102181"},{"key":"1512_CR6","doi-asserted-by":"publisher","first-page":"e1010594","DOI":"10.1371\/journal.ppat.1010594","volume":"18","author":"B Caughey","year":"2022","unstructured":"Caughey B, Standke HG, Artikis E, Hoyt F, Kraus A (2022) Pathogenic prion structures at high resolution. PLoS Pathog 18:e1010594. https:\/\/doi.org\/10.1371\/journal.ppat.1010594","journal-title":"PLoS Pathog"},{"key":"1512_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v11040309","author":"M Rossi","year":"2019","unstructured":"Rossi M, Baiardi S, Parchi P (2019) Understanding prion strains: evidence from studies of the disease forms affecting humans. Viruses. https:\/\/doi.org\/10.3390\/v11040309","journal-title":"Viruses"},{"key":"1512_CR8","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1038\/s41467-022-31460-8","volume":"13","author":"GC Telling","year":"2022","unstructured":"Telling GC (2022) The shape of things to come: structural insights into how prion proteins encipher heritable information. Nat Commun 13:4003. https:\/\/doi.org\/10.1038\/s41467-022-31460-8","journal-title":"Nat Commun"},{"key":"1512_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224\u2013233","journal-title":"Ann Neurol"},{"key":"1512_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-019-0742-2","volume":"7","author":"BR Groveman","year":"2019","unstructured":"Groveman BR, Foliaki ST, Orru CD, Zanusso G, Carroll JA, Race B, Haigh CL (2019) Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun 7:90. https:\/\/doi.org\/10.1186\/s40478-019-0742-2","journal-title":"Acta Neuropathol Commun"},{"key":"1512_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, Homfray T, Penninger JM, Jackson AP, Knoblich JA (2013) Cerebral organoids model human brain development and microcephaly. Nature 501:373\u2013379. https:\/\/doi.org\/10.1038\/nature12517","journal-title":"Nature"},{"key":"1512_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12929-021-00728-4","volume":"28","author":"N Sun","year":"2021","unstructured":"Sun N, Meng X, Liu Y, Song D, Jiang C, Cai J (2021) Applications of brain organoids in neurodevelopment and neurological diseases. J Biomed Sci 28:30. https:\/\/doi.org\/10.1186\/s12929-021-00728-4","journal-title":"J Biomed Sci"},{"key":"1512_CR13","doi-asserted-by":"publisher","first-page":"e1009747","DOI":"10.1371\/journal.ppat.1009747","volume":"17","author":"BR Groveman","year":"2021","unstructured":"Groveman BR, Smith A, Williams K, Haigh CL (2021) Cerebral organoids as a new model for prion disease. PLoS Pathog 17:e1009747. https:\/\/doi.org\/10.1371\/journal.ppat.1009747","journal-title":"PLoS Pathog"},{"key":"1512_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.4103\/1673-5374.270300","volume":"15","author":"BR Groveman","year":"2020","unstructured":"Groveman BR, Walters R, Haigh CL (2020) Using our mini-brains: cerebral organoids as an improved cellular model for human prion disease. Neural Regen Res 15:1019\u20131020. https:\/\/doi.org\/10.4103\/1673-5374.270300","journal-title":"Neural Regen Res"},{"key":"1512_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-022-03589-x","author":"RO Walters","year":"2022","unstructured":"Walters RO, Haigh CL (2022) Organoids for modeling prion diseases. Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-022-03589-x","journal-title":"Cell Tissue Res"},{"key":"1512_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrm2204","volume":"8","author":"A Aguzzi","year":"2007","unstructured":"Aguzzi A, Heikenwalder M, Polymenidou M (2007) Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 8:552\u2013561. https:\/\/doi.org\/10.1038\/nrm2204","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1512_CR17","doi-asserted-by":"publisher","first-page":"8546","DOI":"10.1073\/pnas.1204498109","volume":"109","author":"NR Deleault","year":"2012","unstructured":"Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S (2012) Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 109:8546\u20138551. https:\/\/doi.org\/10.1073\/pnas.1204498109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1512_CR18","doi-asserted-by":"publisher","DOI":"10.4161\/pri.27836","author":"IV Baskakov","year":"2014","unstructured":"Baskakov IV (2014) The many shades of prion strain adaptation. Prion. https:\/\/doi.org\/10.4161\/pri.27836","journal-title":"Prion"},{"key":"1512_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-022-03665-2","author":"AJ Block","year":"2022","unstructured":"Block AJ, Bartz JC (2022) Prion strains: shining new light on old concepts. Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-022-03665-2","journal-title":"Cell Tissue Res"},{"key":"1512_CR20","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1099\/vir.0.013227-0","volume":"90","author":"DL Ritchie","year":"2009","unstructured":"Ritchie DL, Boyle A, McConnell I, Head MW, Ironside JW, Bruce ME (2009) Transmissions of variant Creutzfeldt-Jakob disease from brain and lymphoreticular tissue show uniform and conserved bovine spongiform encephalopathy-related phenotypic properties on primary and secondary passage in wild-type mice. J Gen Virol 90:3075\u20133082. https:\/\/doi.org\/10.1099\/vir.0.013227-0","journal-title":"J Gen Virol"},{"key":"1512_CR21","doi-asserted-by":"publisher","first-page":"e0216621","DOI":"10.1371\/journal.pone.0216621","volume":"14","author":"E McNulty","year":"2019","unstructured":"McNulty E, Nalls AV, Mellentine S, Hughes E, Pulscher L, Hoover EA, Mathiason CK (2019) Comparison of conventional, amplification and bio-assay detection methods for a chronic wasting disease inoculum pool. PLoS ONE 14:e0216621. https:\/\/doi.org\/10.1371\/journal.pone.0216621","journal-title":"PLoS ONE"},{"key":"1512_CR22","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3201\/eid1509.090253","volume":"15","author":"B Race","year":"2009","unstructured":"Race B, Meade-White KD, Miller MW, Barbian KD, Rubenstein R, LaFauci G, Cervenakova L, Favara C, Gardner D, Long D et al (2009) Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis 15:1366\u20131376. https:\/\/doi.org\/10.3201\/eid1509.090253","journal-title":"Emerg Infect Dis"},{"key":"1512_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40478-020-00958-x","volume":"8","author":"A Ward","year":"2020","unstructured":"Ward A, Hollister JR, McNally K, Ritchie DL, Zanusso G, Priola SA (2020) Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes. Acta Neuropathol Commun 8:83. https:\/\/doi.org\/10.1186\/s40478-020-00958-x","journal-title":"Acta Neuropathol Commun"},{"key":"1512_CR24","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1128\/JVI.00362-15","volume":"89","author":"B Race","year":"2015","unstructured":"Race B, Phillips K, Meade-White K, Striebel J, Chesebro B (2015) Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein. J Virol 89:6022\u20136032. https:\/\/doi.org\/10.1128\/JVI.00362-15","journal-title":"J Virol"},{"key":"1512_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9060482","author":"ST Foliaki","year":"2020","unstructured":"Foliaki ST, Groveman BR, Yuan J, Walters R, Zhang S, Tesar P, Zou W, Haigh CL (2020) Pathogenic prion protein isoforms are not present in cerebral organoids generated from asymptomatic donors carrying the E200K mutation associated with familial prion disease. Pathogens (Basel, Switzerland). https:\/\/doi.org\/10.3390\/pathogens9060482","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"1512_CR26","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1038\/s41598-021-84689-6","volume":"11","author":"BR Groveman","year":"2021","unstructured":"Groveman BR, Ferreira NC, Foliaki ST, Walters RO, Winkler CW, Race B, Hughson AG, Zanusso G, Haigh CL (2021) Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease. Sci Rep 11:5165. https:\/\/doi.org\/10.1038\/s41598-021-84689-6","journal-title":"Sci Rep"},{"key":"1512_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/acn3.378","volume":"4","author":"BR Groveman","year":"2017","unstructured":"Groveman BR, Orru CD, Hughson AG, Bongianni M, Fiorini M, Imperiale D, Ladogana A, Pocchiari M, Zanusso G, Caughey B (2017) Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann Clin Transl Neurol 4:139\u2013144. https:\/\/doi.org\/10.1002\/acn3.378","journal-title":"Ann Clin Transl Neurol"},{"key":"1512_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","volume":"371","author":"CD Orru","year":"2014","unstructured":"Orru CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, Fiorini M, Pocchiari M, Monaco S, Caughey B et al (2014) A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med 371:519\u2013529. https:\/\/doi.org\/10.1056\/NEJMoa1315200","journal-title":"N Engl J Med"},{"key":"1512_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13567-019-0626-2","volume":"50","author":"B Race","year":"2019","unstructured":"Race B, Williams K, Chesebro B (2019) Transmission studies of chronic wasting disease to transgenic mice overexpressing human prion protein using the RT-QuIC assay. Vet Res 50:6. https:\/\/doi.org\/10.1186\/s13567-019-0626-2","journal-title":"Vet Res"},{"key":"1512_CR30","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1038\/s41467-022-30457-7","volume":"13","author":"SW Manka","year":"2022","unstructured":"Manka SW, Zhang W, Wenborn A, Betts J, Joiner S, Saibil HR, Collinge J, Wadsworth JDF (2022) 2.7 A cryo-EM structure of ex vivo RML prion fibrils. Nat Commun 13:4004. https:\/\/doi.org\/10.1038\/s41467-022-30457-7","journal-title":"Nat Commun"},{"key":"1512_CR31","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1038\/s41467-022-30458-6","volume":"13","author":"F Hoyt","year":"2022","unstructured":"Hoyt F, Standke HG, Artikis E, Schwartz CL, Hansen B, Li K, Hughson AG, Manca M, Thomas OR, Raymond GJ et al (2022) Cryo-EM structure of anchorless RML prion reveals variations in shared motifs between distinct strains. Nat Commun 13:4005. https:\/\/doi.org\/10.1038\/s41467-022-30458-6","journal-title":"Nat Commun"},{"key":"1512_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213\u2013239. https:\/\/doi.org\/10.1093\/bmb\/66.1.213","journal-title":"Br Med Bull"},{"key":"1512_CR33","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1093\/emboj\/cdf653","volume":"21","author":"EA Asante","year":"2002","unstructured":"Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, Welch J, Hill AF, Lloyd SE, Wadsworth JD et al (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21:6358\u20136366. https:\/\/doi.org\/10.1093\/emboj\/cdf653","journal-title":"EMBO J"},{"key":"1512_CR34","doi-asserted-by":"publisher","first-page":"10759","DOI":"10.1073\/pnas.0604292103","volume":"103","author":"EA Asante","year":"2006","unstructured":"Asante EA, Linehan JM, Gowland I, Joiner S, Fox K, Cooper S, Osiguwa O, Gorry M, Welch J, Houghton R et al (2006) Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A 103:10759\u201310764. https:\/\/doi.org\/10.1073\/pnas.0604292103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1512_CR35","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1073\/pnas.0800190105","volume":"105","author":"JD Wadsworth","year":"2008","unstructured":"Wadsworth JD, Joiner S, Linehan JM, Desbruslais M, Fox K, Cooper S, Cronier S, Asante EA, Mead S, Brandner S et al (2008) Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A 105:3885\u20133890. https:\/\/doi.org\/10.1073\/pnas.0800190105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1512_CR36","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1073\/pnas.1004688107","volume":"107","author":"MT Bishop","year":"2010","unstructured":"Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 107:12005\u201312010. https:\/\/doi.org\/10.1073\/pnas.1004688107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1512_CR37","doi-asserted-by":"publisher","first-page":"e1005914","DOI":"10.1371\/journal.ppat.1005914","volume":"12","author":"AG Hughson","year":"2016","unstructured":"Hughson AG, Race B, Kraus A, Sangare LR, Robins L, Groveman BR, Saijo E, Phillips K, Contreras L, Dhaliwal V et al (2016) Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid. PLoS Pathog 12:e1005914. https:\/\/doi.org\/10.1371\/journal.ppat.1005914","journal-title":"PLoS Pathog"},{"key":"1512_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1099\/vir.0.069906-0","volume":"96","author":"DM Henderson","year":"2015","unstructured":"Henderson DM, Davenport KA, Haley NJ, Denkers ND, Mathiason CK, Hoover EA (2015) Quantitative assessment of prion infectivity in tissues and body fluids by real-time quaking-induced conversion. J Gen Virol 96:210\u2013219. https:\/\/doi.org\/10.1099\/vir.0.069906-0","journal-title":"J Gen Virol"},{"key":"1512_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7785","author":"CD Orru","year":"2017","unstructured":"Orru CD, Yuan J, Appleby BS, Li B, Li Y, Winner D, Wang Z, Zhan YA, Rodgers M, Rarick J et al (2017) Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aam7785","journal-title":"Sci Transl Med"},{"key":"1512_CR40","doi-asserted-by":"publisher","first-page":"e1001217","DOI":"10.1371\/journal.ppat.1001217","volume":"6","author":"JM Wilham","year":"2010","unstructured":"Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B, Meade-White KD, Taubner LM, Timmes A, Caughey B (2010) Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6:e1001217. https:\/\/doi.org\/10.1371\/journal.ppat.1001217","journal-title":"PLoS Pathog"},{"key":"1512_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13567-022-01130-0","volume":"53","author":"B Race","year":"2022","unstructured":"Race B, Baune C, Williams K, Striebel JF, Hughson AG, Chesebro B (2022) Second passage experiments of chronic wasting disease in transgenic mice overexpressing human prion protein. Vet Res 53:111. https:\/\/doi.org\/10.1186\/s13567-022-01130-0","journal-title":"Vet Res"},{"key":"1512_CR42","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1126\/science.1190815","volume":"328","author":"J Collinge","year":"2010","unstructured":"Collinge J (2010) Medicine Prion strain mutation and selection. Science 328:1111\u20131112. https:\/\/doi.org\/10.1126\/science.1190815","journal-title":"Science"},{"key":"1512_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1126\/science.1183218","volume":"327","author":"J Li","year":"2010","unstructured":"Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C (2010) Darwinian evolution of prions in cell culture. Science 327:869\u2013872. https:\/\/doi.org\/10.1126\/science.1183218","journal-title":"Science"},{"key":"1512_CR44","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","volume":"23","author":"C Gonzalez","year":"2018","unstructured":"Gonzalez C, Armijo E, Bravo-Alegria J, Becerra-Calixto A, Mays CE, Soto C (2018) Modeling amyloid beta and tau pathology in human cerebral organoids. Mol Psychiatry 23:2363\u20132374. https:\/\/doi.org\/10.1038\/s41380-018-0229-8","journal-title":"Mol Psychiatry"},{"key":"1512_CR45","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s12035-017-0506-6","volume":"55","author":"A Matamoros-Angles","year":"2018","unstructured":"Matamoros-Angles A, Gayosso LM, Richaud-Patin Y, di Domenico A, Vergara C, Hervera A, Sousa A, Fern\u00e1ndez-Borges N, Consiglio A, Gav\u00edn R et al (2018) iPS Cell Cultures from a Gerstmann-Str\u00e4ussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology. Mol Neurobiol 55:3033\u20133048. https:\/\/doi.org\/10.1007\/s12035-017-0506-6","journal-title":"Mol Neurobiol"},{"key":"1512_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13041-021-00864-w","volume":"14","author":"ST Foliaki","year":"2021","unstructured":"Foliaki ST, Schwarz B, Groveman BR, Walters RO, Ferreira NC, Orru CD, Smith A, Wood A, Schmit OM, Freitag P et al (2021) Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases. Mol Brain 14:156. https:\/\/doi.org\/10.1186\/s13041-021-00864-w","journal-title":"Mol Brain"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01512-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01512-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01512-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T16:17:43Z","timestamp":1676909863000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01512-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1512"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01512-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Use of mice for the scientific research included in this manuscript was approved by the Institutional Animal Care and Use Committee of the Rocky Mountain Laboratories (RML) protocols 2019\u2013007-E and 2022\u2013006-E. Mouse handling and housing was conducted adhering to the institution\u2019s guidelines for animal use, and followed the guidelines and basic principles in the United States Public Health Service Policy on Humane Care and Use of Laboratory Animals, and the Guide for the Care and Use of Laboratory Animals. Work was carried out by certified staff in an Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International accredited facility. All human brain tissues used in this study were obtained on autopsy and were therefore exempt from review by the NIH Office of Human Subjects Research Protections.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}